As of 2024-12-11, the Relative Valuation of Oasmia Pharmaceutical AB (OASM.ST) is (7.27) Oasmia Pharmaceutical. This relative valuation is based on P/E multiples. With the latest stock price at 1.69 Oasmia Pharmaceutical, the upside of Oasmia Pharmaceutical AB based on Relative Valuation is -348.8%.
The range of the Relative Valuation is (7.77) - (14.26) Oasmia Pharmaceutical.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.2x - 37.5x | 19.5x |
| Forward P/E multiples | 10.0x - 35.2x | 16.4x |
| Fair Price | (7.77) - (14.26) | (7.27) |
| Upside | -366.1% - -588.5% | -348.8% |
| Date | P/E |